
New findings, published in Nature, show that a protein called GREM1 is key to regulating the type of cells found …

A class of viruses known to cause severe diarrheal diseases can grow in the salivary glands of mice and spread …

A start-up, called Priovant Therapeutics, has been formed to develop a JAK1/TYK2 inhibitor originated by Pfizer as a treatment for …

NICE has issued a positive Final Appraisal Document (FAD) which recommends tralokinumab, upadacitinib and abrocitinib for use within NHS England …
The NHS app will be updated over the next few years to include multiple new features, including remote video consultations …

Automata has announced a commercial collaboration with University Hospital Southampton (UHS) NHS Foundation Trust, to accelerate automation within laboratories, enhance …

Members of the British Medical Association (BMA) have voted to press ministers to agree to a pay rise of up …

Basilea Pharmaceutica has announced positive topline results for the Phase III ERADICATE study, evaluating ceftobiprole in the treatment of adult …

The EMA has granted access to its priority medicines (PRIME) scheme for MVA-BN RSV in the active immunisation for the …

The CHMP of the EMA has adopted a positive opinion for the marketing authorisation of a bevacizumab biosimilar candidate, Vegzelma. …

Telehealth abortion clinics have shared that they are still offering pills to people outside of their states, following the Supreme …

The National Medical Products Administration (NMPA) has approved the supplemental NDA for TYVYT (sintilimab injection) in combination with fluorouracil and …

NHS patients in England, who have been waiting over two years for surgery are being offered hospital treatment in certain …

The CHMP has recommended upadacitinib (RINVOQ® 15 mg, once daily) for approval, for the treatment of adults with active non-radiographic …

Traces of the polio virus have been found during a routine sewage inspection in London. The UKHSA has consequently declared …

Anumana has announced the FDA had granted Breakthruogh Device Designation to its AI-enhanced ECG-based Pulmonary Hypertension (PH) Early Detection Algorithm. …

Cumulus Neuroscience has announced the start of two validation trials – CNS-101 and CNS-102 – supported by a group of …

Dr Tedros Adhanom Gebreyesus has delivered a message at the opening of the 75th World Health Assembly. He highlighted: “So, …

The JCVI has advised the government to provide an autumn COVID-19 booster programme in preparation for the winter. The recommendations …

Pierre Fabre and the European Organisation for Research and Treatment of Cancer (EORTC) have announced the screening of the first …